Execs On The Move: Tearlab Gets New President; Invion Hires Finance Chief
Cogentix chair takes on multiple roles at Tearlab, including president; new Invion finance chief comes from Genera Biosystems; several medtech boards hire new directors; and more.
You may also be interested in...
Suspension of heartburn remedy ranitidine looming in the EU as the European Medicines Agency stands by its original decision.
Illumina announced on 21 September it will buy back Grail, which is planning to commercialize its multi-cancer early detection blood test Galleri in 2021. See what Illumina’s CEO Francis deSouza said about it here.
Yes, Gottlieb’s in there twice; things get complicated when an agency starts to lose credibility.